Aphria and Liberty Health Sciences Announce Definitive Agreement for Sale of Aphria's Investment in Copperstate Farms to Liberty

Aphria Inc. (TSX: APH or OTCQB: APHQF) and Liberty Health Sciences Inc. (CSE:LHS or OTCQB:LHSIF) jointly announce that they have entered into a definitive agreement with respect to the sale of Aphria's subsidiary Aphria Inc. and its sole holdings being the minority membership interests in Copperstate Farms, LLC and Copperstate Farms Investors, LLC to Liberty for a purchase price of $20 million.

Eyechronic Receives $3 Million in Funding From Tuatara Capital

Eyechronic, a leading marketing platform for cannabis dispensaries and brands, today announced it secured $3 million in Series A funding from Tuatara Capital, L.P., a specialized alternative investment manager focused on supporting high-growth companies in the legal cannabis industry.

Hiku Brands to acquire leading Quebec based cannabis brand Maïtri

Hiku Brands Company Ltd. (CSE: HIKU), Canada's first vertically-integrated cannabis brand house, is pleased to announce it has entered into a binding letter of intent to acquire 100% of the issued and outstanding shares of Maïtri Group Inc., a Quebec-based cannabis accessory and design brand. The proposed acquisition represents the first brand acquisition by Hiku.

Organigram Announces Closing of $115 Million Convertible Debenture Bought Deal Financing

Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce that it has closed its previously announced short form prospectus offering of convertible unsecured debentures of the Company, on a bought deal basis, including the full exercise of the over-allotment option.

MedReleaf Corp. Announces Closing of Previously Announced Offering

MedReleaf Corp. (TSX:LEAF) is pleased to announce that it has closed its previously announced offering, on a "bought deal" basis, pursuant to a short form prospectus, of an aggregate of 5,000,000 units of the Company at a price of $26.50 per Unit for aggregate gross proceeds to the Company of $132,500,000.